Emmaus Life Sciences Inc (EMMA)

HEALTH CARE: HEALTH CARE SERVICES
SIC: PHARMACEUTICAL PREPARATIONS

21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE, CA 90503

CNS Response, Inc., formerly Strativation, Inc., is engaged in seeking an acquisition, locating a new business opportunity, finding a business partner, or locating a qualified company as a candidate for a business combination. Commencing January 1, 2004, the Company ceased operations. The Company has not generated revenues from the sale of any products. On January 16, 2007, the Company entered into an agreement and plan of merger with CNS Merger Corporation, a California corporation and wholly owned subsidiary of the registrant (MergerCo), and CNS Response, Inc. (CNRS), a California corporation. CNSR's business is focused on the commercialization of a system that aids physicians in the identification and determination of appropriate medications for patients with certain behavioral (mental or addictive) disorders. In a series of transactions consummated in June 2004, the Company acquired all of the outstanding capital stock of NBD Marketing, Inc., (NBD) and SalesWare Inc., (SalesWare), and formed an acquisition subsidiary, xSellsys, Inc., (xSellsys), to acquire substantially all of the assets and liabilities of CRM SalesWare, Inc., (CRM SalesWare). As a result, SalesWare, NBD, and xSellsys became the Company's wholly owned subsidiaries and ProspectWorks, Inc., a subsidiary of NBD, (ProspectWorks), became an indirect, wholly owned subsidiary of the Company. As a result of the acquisition of SalesWare, Inc., on August 2, 2004 the Company changed its corporate name to SalesTactix, Inc. On September 15, 2005, the Company changed its corporate name to Strativation, Inc.

Data as of 2020-08-01
Market Cap92.58 Million Shares Outstanding48.471 Million Avg 30-day Volume27.964 Thousand
P/E Ratio Dividend Yield EPS-5.34
Price/Sales5.364 Price cash flow ratio Price free cash flow ratio-14.2
Book Value-0.36 Price to Tangible Book-5.49 Alpha-0.04
Short Interest Ratio0.48 % Short Interest to Float0.1 R-squared0.128572
BETA2.55337 52-week High/Low5.68 / 0.85 Stddev0.352873
View SEC Filings from EMMA instead.
Q1 2020 All Institutions Hedge Funds 1
No data found for this quarter.
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

 
Emmaus Life Sciences Inc Chart by YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Check out our reporting and analysis

Funds Holding EMMA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding EMMA BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

3.4 Thousand total shares from 4 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

NIIHARA YUTAKA CHAIRMAN AND CEO

  • Officer
  • Director
  • 10% Owner
 10,830,340 2020-08-11 48

SASSINE ANDY

  • Director
 1,334,882 2020-08-06 0

THOMPSON TOMMY G

  • Director
 383,266 2020-06-30 0

DICKEY ROBERT IV

  • Director
  • INDEPENDENT DIRECTOR
 0 2020-06-30 0

SMITH ROBIN L

  • Director
 0 2020-06-15 0

VOTRUBA MICHAL

  • Director
 0 2020-05-21 0

LEE WILLIS C VICE CHAIRMAN & COO

  • Officer
  • Director
 324,385 2020-03-30 13

WOOD JANE PINE

  • Director
 0 2020-03-25 1

OMAN MARK C

  • Director
 34,042 2020-02-20 0

ZEN WEI PEU

  • Director
 3,358,711 2019-09-09 5

HARRIS GEOFFREY E.

  • Director
 0 2019-07-23 0

SHERWOOD JOSEPH CHARLES III CHIEF FINANCIAL OFFICER

  • Officer
 0 2019-07-17 0

ZWICKER IAN HARVEY

  • Director
 0 2019-07-17 0

NAGASAKI YASUSHI SR. VP FINANCE

  • Officer
 67,102 2019-07-17 0

TRAN LAN T. CHIEF ADMINISTRATIVE OFFICER

  • Officer
 26,562 2019-07-17 0

OSATO MASAHARU

  • Director
 518,367 2019-07-17 0

PAPPAJOHN JOHN

  • Director
  • 10% Owner
 1,132,925 2019-07-16 0

D'AMBROSIO DONALD ERIC CHIEF FINANCIAL OFFICER

  • Officer
 7,500 2019-07-16 0

UNANUE PETER

  • Director
 126,627 2019-07-16 0

HERGUTH PATRICK CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
 0 2019-06-25 0

CARPENTER GEORGE C IV CHIEF INNOVATION OFFICER

  • Officer
 0 2018-12-12 0

RSJ INVESTMENTS SICAV A.S. ACTING IN RESPECT OF ITS SUB-FUND (PODFOND) RSJ GRADUS PODFOND, RSJ INVESTMENT SICAV A.S.

  • 10% Owner
 1,056,474 2018-10-08 0

TIERNEY THOMAS T

  • Director
  • 10% Owner
 236,345 2016-11-30 0

BUCK PAUL CHIEF FINANCIAL OFFICER

  • Officer
 0 2016-11-01 0

MCADOO ZACHARY

  • FORMER DIRECTOR
 No longer subject to file 2016-11-01 0

FOLLMAN ROBERT J

  • Director
 167,781 2016-11-01 0

TURNER RICHARD W CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
 0 2014-07-30 0

SCHINDLER WALTER

  • Director
 6,069,376 2014-07-11 0

DARKOCH MICHAEL EXECUTIVE VP & CMO

  • Officer
 53,333 2012-11-28 0

JONES DAVID B

  • Director
  • 10% Owner
 0 2011-02-28 0

KALLINS GEORGE J

  • Director
 0 2010-11-03 0

JONES DAVID B

SAIL VENTURE PARTNERS LP

SAIL VENTURE PARTNERS LLC

  • Director
  • 10% Owner
 0 2010-11-03 0

HARBIN HENRY T

  • Director
 0 2010-03-03 0

HOFFMAN DANIEL A PRESIDENT AND CMO

  • Officer
 0 2010-03-03 0

VACCARO JEROME

  • Director
 0 2010-03-03 0

BRANDT LEONARD J.

  • Director
  • 10% Owner
 8,890,795 2009-08-26 0

SAIL VENTURE PARTNERS LP

  • 10% Owner
 3,632,711 2009-06-30 0

SAIL VENTURE PARTNERS LLC

  • 10% Owner
 3,632,711 2009-06-30 0

LUCE BRADLEY V.P. FINANCE & CONTROLLER

  • Officer
 No longer subject to file 2008-09-17 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

NIIHARA YUTAKA - Director - Officer - > 10% Owner CHAIRMAN AND CEO

2020-08-12 P 850 $1.53 a 10,674,546 10,830,340.00 direct

NIIHARA YUTAKA - Director - Officer - > 10% Owner CHAIRMAN AND CEO

2020-08-11 P 303 $1.87 a 10,673,696 10,830,340.00 direct

NIIHARA YUTAKA - Director - Officer - > 10% Owner CHAIRMAN AND CEO

2020-06-19 P 1,200 $1.74 a 10,673,393 10,829,187.00 direct

NIIHARA YUTAKA - Director - Officer - > 10% Owner CHAIRMAN AND CEO

2020-06-16 P 1,000 $1.67 a 10,672,193 10,827,987.00 direct
Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments